EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
WALTHAM, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the more...
Contango Announces Second Quarter 2021 Financial Results and Capital Program Update
FORT WORTH, Texas, Aug. 11, 2021 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today its financial results for the second quarter ended June 30, 2021. Second more...
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update
Ended second quarter 2021 with $36.8 million in cash and cash equivalents On May 16, 2021, Aerpio entered into an agreement and plan of merger with Aadi Bioscience, Inc., which is subject to the approval more...
Almadex Retains Rights to 100% of Drill-Ready Davis/Paradise Valley Property, Nevada
VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) reports that the option agreement it announced on September 14, 2020 with Makara Mining Corp. (“Makara”), regarding the Davis/Paradise more...
Kewaunee Scientific Corporation Announces Distribution Partnership with NuAire
Kewaunee Scientific Corporation Announces Distribution Partnership with NuAire PR Newswire STATESVILLE, N.C. , Aug. 11, 2021 /PRNewswire/ — Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, more...
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Thursday, August 12, at 8:00 a.m. U.S. Eastern Time PR Newswire Strong balance sheet more...
Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
-Management to Host Conference Call on August 12 at 8am ET- Patient Enrollment in the ATTACK Phase 3 Registrational Trial Completed; Top-Line Data Readout Expected Early Fourth Quarter 2021 SUL-DUR Launch Planning Progresses with Appointment more...
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine more...
Heat Biologics Provides Second Quarter 2021 Business Update
DURHAM, N.C., Aug. 11, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided financial, clinical and operational more...
Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
– Announces First Patients with Solid Tumors Dosed with Oral Fadraciclib – – Additional Phase 1/2 Trials for Fadraciclib and CYC140 Expected to Follow – – Cash Runway to Early 2023 – – Conference Call more...